Effect of Dynamic Arterial Elastance and Assisted Fluid Management Software Guided Resuscitation in Septic Shock: Pilot Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMahidol University

About this trial

To investigate the benefit of using the AFM and Eadyn-guided fluid and vasopressor therapy in septic shock resuscitation for mechanically ventilated patients compared with the standard of care. The investigators hypothesize that using the AFM and Eadyn-guided fluid/vasopressor titration in septic shock patients who underwent mechanical ventilation might reduce the time to shock reversal.

Eligibility criteria

Qualifiers

All Thai consecutive patients older than 18 years with a diagnosis of sepsis or septic shock in medical ICU, defined by clinically suspected or confirmed infection and MAP <65 mmHg according to the criteria of the Surviving Sepsis Campaign 2021(11)with onset of shock in less than 24 hours.

Already receiving or planning for mechanical ventilation

Already receiving or planning for arterial catheter placement for invasive arterial pressure monitoring

All patients will receive an echocardiogram with a cut point of LVEF > 30% to be included in the study

Disqualifiers

Active, immediate, life-threatening cardiac arrhythmia, defined as ventricular tachycardia and ventricular fibrillation

Acute cerebral vascular event, including both acute ischemic stroke or intracranial hemorrhage

Acute coronary syndrome

cardiogenic shock, acute heart failure

Trial design

Treatments tested in this trial

  • The AFM and Eadyn - guided resuscitation group
  • The standard care for septic shock

Treatment groups

60 Participants
are divided into 2 treatment groups

Sponsors and collaborators